Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

456 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Psychometrics of the Concise Health Risk Tracking Self-Report (CHRT-SR16) Assessment of Suicidality in a Sample of Adults with Moderate to Severe Methamphetamine Use Disorder: Findings from the ADAPT-2 Randomized Trial.
Trombello JM, Kulikova A, Mayes TL, Nandy K, Carmody T, Bart G, Nunes EV, Schmitz J, Kalmin M, Shoptaw S, Trivedi MH. Trombello JM, et al. Among authors: shoptaw s. Neuropsychiatr Dis Treat. 2023 Jun 22;19:1443-1454. doi: 10.2147/NDT.S406909. eCollection 2023. Neuropsychiatr Dis Treat. 2023. PMID: 37377462 Free PMC article.
Naltrexone plus bupropion reduces cigarette smoking in individuals with methamphetamine use disorder: A secondary analysis from the CTN ADAPT-2 trial.
Schmitz JM, Stotts AL, Yoon JH, Northrup TF, Villarreal YR, Yammine L, Weaver MF, Carmody T, Shoptaw S, Trivedi MH. Schmitz JM, et al. Among authors: shoptaw s. J Subst Use Addict Treat. 2023 Aug;151:208987. doi: 10.1016/j.josat.2023.208987. Epub 2023 Feb 21. J Subst Use Addict Treat. 2023. PMID: 36822269 Free PMC article. Clinical Trial.
A phase 3 randomised double-blind placebo-controlled trial of mirtazapine as a pharmacotherapy for methamphetamine use disorder: a study protocol for the Tina Trial.
McKetin R, Degan TJ, Saunders L, Nguyen L, Dore G, Shoptaw S, Farrell M, Degenhardt L, Kelly PJ, Turner A, Clare PJ, Dean OM, Arunogiri S, Colledge-Frisby S, Koeijers J, Goodman-Meza D, Sinclair B, Reid D, Hill H, Hayllar J, Christmass M, Cordaro F, Lundin R, Liaw W, Liu D, Holyoak E, Wu BT, Keygan J, Kontogiannis A, Palmer L, Morrison C, Wrobel A, Hyland B, Byrne M, Russell S, Zahra E, Berk M. McKetin R, et al. Among authors: shoptaw s. Trials. 2024 Jun 22;25(1):408. doi: 10.1186/s13063-024-08238-y. Trials. 2024. PMID: 38907288 Free PMC article.
Lisdexamfetamine for the treatment of acute methamphetamine withdrawal: A pilot feasibility and safety trial.
Acheson LS, Ezard N, Lintzeris N, Dunlop A, Brett J, Rodgers C, Gill A, Christmass M, McKetin R, Farrell M, Shoptaw S, Siefried KJ. Acheson LS, et al. Among authors: shoptaw s. Drug Alcohol Depend. 2022 Dec 1;241:109692. doi: 10.1016/j.drugalcdep.2022.109692. Epub 2022 Nov 7. Drug Alcohol Depend. 2022. PMID: 36399936 Free article. Clinical Trial.
Creating a standard inpatient opioid withdrawal protocol.
Abid A, Shoptaw S, Bholat M. Abid A, et al. Among authors: shoptaw s. MedEdPublish (2016). 2022 Feb 4;12:7. doi: 10.12688/mep.17533.1. eCollection 2022. MedEdPublish (2016). 2022. PMID: 37496831 Free PMC article.
456 results